FOXO (FOXO Technologies) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


What is FOXO Technologies Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

FOXO Technologies's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


FOXO vs WORX, MSPR, ESSID: Margin of Safety % (DCF FCF Based) Comparison

For the Health Information Services subindustry, FOXO Technologies's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FOXO Technologies Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, FOXO Technologies's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where FOXO Technologies's Margin of Safety % (DCF FCF Based) falls into.



FOXO Technologies Business Description

Address 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL, USA, 33401
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.